Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPATH Study: Eplerenone in Primary Hyperparathyroidism
2011-005683-21Phase 3Completed
- Sponsor
- Medical University of Graz
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in primary hyperparathyroidism (PHPT), sponsored by Medical University of Graz. Started Sep 2012; status: completed.
02
Drugs
eplerenone
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on 2011-005683-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005683-21.